TCRX Tscan Therapeutics Inc
Company Analysis
Latest News
🔴 Tscan Therapeutics is trading 10.4% down today as biotech-sector weakness may contribute
Tscan Therapeutics is trading at $0.25, down 10.40%, with biotech-sector weakness a possible contributing factor; the available information does not establish...
🔴 Tscan Therapeutics is trading 5% down today alongside Nasdaq Composite's 0.54% decline
Tscan Therapeutics is trading 5.34% down at $0.26, alongside broader market weakness; no specific company catalyst was identified. - No company-specific...
🟢 Tscan Therapeutics is trading 5.3% up in after-hours trading with no clear company-specific catalyst identified
Tscan Therapeutics is trading at $0.29, up +5.30% after-hours, with no clear company-specific catalyst identified for the October 6 increase. - The company’s...
🔴 Tscan Therapeutics is trading 10.5% down with no clear catalyst identified
Tscan Therapeutics is trading 10.5% lower at $0.26, with no clear company-specific catalyst identified. - No new company-specific announcement or clear...
🔴 Tscan Therapeutics is trading 5.5% down amid biotech-sector weakness, with no clear catalyst
Tscan Therapeutics is trading 5.5% lower at $0.28 on October 6, 2026, with no clear company-specific catalyst identified. - The latest investor-relations...
🔴 Tscan Therapeutics is trading 10.45% down — no clear catalyst identified
Tscan Therapeutics is trading at $0.29, down 10.45%, with no clearly identified catalyst for the October 5, 2026 decline. - No new company announcement...
🔴 Tscan Therapeutics is trading 6% down; no clear catalyst identified
Tscan Therapeutics is trading 5.87% down at $0.30 on October 5, 2026, and the reason for the decline remains unclear. - No new company announcement was listed...
🟢 Tscan Therapeutics is trading 5% up today with broader-market gains a possible contributor
Tscan Therapeutics is trading at $0.33, up +5.45%, with broader-market strength a possible contributor, though the connection is unconfirmed. - No new...
🔴 Tscan Therapeutics is trading 5% down — no clear catalyst identified
Tscan Therapeutics is trading 5.41% lower at $0.32, with no clear company-specific announcement for September 29 explaining the move. - The company’s latest...
🔴 Tscan Therapeutics is trading 5.4% down today
Tscan Therapeutics is trading at $0.33, down 5.39%, with no new company-specific catalyst identified for September 25, 2026. - The latest major company update...
🔴 Tscan Therapeutics is trading 5.27% down today as biotech ETF XBI falls
Tscan Therapeutics is trading 5.27% down now at $0.34, with the decline appearing mainly sector-driven. - No new company-specific announcement or filing was...
🔴 Tscan Therapeutics is trading 8.68% down in pre-market
Tscan Therapeutics is trading at $0.32, down 8.68% in pre-market, with no clear catalyst identified. - No fresh company-specific announcement or filing dated...
🟢 Tscan Therapeutics is trading 5% up today amid a biotech risk-on rotation
Tscan Therapeutics is trading at $0.35, up +5.05%, primarily as part of a broader biotech risk-on rotation. - No fresh company-specific announcement or filing...
🟢 Tscan Therapeutics is trading 6.86% up today as falling oil prices ease inflation concerns
Tscan Therapeutics is trading 6.86% up now at $0.33 after opening amid a broad risk-on rebound. - U.S. equities are gaining as falling oil prices ease...
🟢 Tscan Therapeutics is trading 7% up in pre-market with broader risk-on sentiment
Tscan Therapeutics is trading at $0.33, up +7.02%, with broader pre-market risk-on sentiment the most likely explanation for the move. - Major U.S. indices...
🟢 Tscan Therapeutics is trading 6.6% up in after-hours trading with no clear catalyst identified
Tscan Therapeutics is trading 6.6% up at $0.33, with no clear company-specific announcement or late-breaking catalyst identified. - Shares closed at $0.31 on...
🔴 Tscan Therapeutics is trading 5.6% down today — immediate catalyst unclear
Tscan Therapeutics is trading 5.6% down now at $0.32, with no new company-specific announcement identified for September 18, 2026. - The latest major update...
🟢 Tscan Therapeutics is trading 7.95% up today in pre-market with no company-specific catalyst identified
Tscan Therapeutics is trading 7.95% up now at $0.36 after no new company-specific announcement was identified for September 18, 2026. - The move appears tied...
🟢 Tscan Therapeutics is trading 6.47% up today amid biotech rally and improved risk appetite
Tscan Therapeutics is trading 6.47% up at $0.35 as biotechnology and broader markets rally. - No new company-specific announcement was identified for...
🟢 Tscan Therapeutics is trading 5% up today amid broader risk-on sentiment
Tscan Therapeutics is trading 5.17% up at $0.34, continuing its rebound after reaching $0.31 on September 14. - The stock is recovering from the September 8...